| Central vein sign: A putative diagnostic marker for multiple sclerosis L Chaaban, N Safwan, H Moussa, S El‐Sammak, SJ Khoury, S Hannoun Acta Neurologica Scandinavica 145 (3), 279-287, 2022 | 9 | 2022 |
| Effects of ibudilast on retinal atrophy in progressive multiple sclerosis subtypes: Post hoc analyses of the SPRINT-MS trial H Ehrhardt, J Lambe, H Moussa, ES Vasileiou, G Kalaitzidis, OC Murphy, ... Neurology 101 (10), e1014-e1024, 2023 | 7 | 2023 |
| Spinal cord infarction in a young adult: What is the culprit? M Khoueiry, H Moussa, R Sawaya The Journal of Spinal Cord Medicine 44 (6), 1015-1018, 2021 | 5 | 2021 |
| Visual pathway involvement in NMDA receptor encephalitis: a clinical, optical coherence tomography, and 18-Fluorodeoxyglucose PET/CT approach G Kalaitzidis, A Filippatou, N Fioravante, A Rothman, ES Sotirchos, ... Journal of Neuro-Ophthalmology 43 (2), 220-226, 2023 | 1 | 2023 |
| Correlation of pattern reversal and Flash Visual evoked potential latencies with Optical Coherence Tomography measures in patients with Optic Neuropathy and patients with … H Moussa, RA Sawaya, R Deeb, N El Ayoubi Journal of Clinical Neurophysiology 39 (7), 637-642, 2022 | 1 | 2022 |
| Rituximab treatment for chronic idiopathic axonal polyneuropathy H Moussa, RA Sawaya Journal of Clinical Neuromuscular Disease 22 (4), 214-219, 2021 | 1 | 2021 |
| Synaptic Protein Loss in Extracellular Vesicles Reflects Brain and Retinal Atrophy in People With Multiple Sclerosis DC Ladakis, M Vreones, J Blommer, KL Harrison, MD Smith, ES Vasileiou, ... Neurology: Neuroimmunology & Neuroinflammation 11 (4), e200257, 2024 | | 2024 |
| Synaptic protein loss reflects brain and retinal atrophy in people with multiple sclerosis D Ladakis, M Vreones, J Blommer, K Harrison, M Smith, E Vasileiou, ... MULTIPLE SCLEROSIS JOURNAL 29, 297-297, 2023 | | 2023 |
| Hemi-macular atrophy in multiple sclerosis: A clinically relevant surrogate of trans-synaptic neurodegeneration that is associated with disability and extends beyond the inner … O Ezzedin, G Kalaitzidis, H Moussa, D Ladakis, J Lambe, A Filippatou, ... MULTIPLE SCLEROSIS JOURNAL 29, 117-117, 2023 | | 2023 |
| Vitreomacular Interface Abnormalities in Multiple Sclerosis; A Novel Signature of Disability (P10-3.013) H Moussa, G Kalaitzidis, H Ehrhardt, O Murphy, E Vasileiou, G Ahmadi, ... Neurology 100 (17_supplement_2), 2054, 2023 | | 2023 |
| Effects of Myopia on Rates of Change in Optical Coherence Tomography Measured Retinal Layer Thicknesses in People with Multiple Sclerosis and Healthy Controls G Kalaitzidis, N Pellegrini, N Nagy, E Vasileiou, H Ehrhardt, A Reppen, ... Current Eye Research 48 (3), 312-319, 2023 | | 2023 |
| Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study NK El Ayoubi, H Moussa, A Younes, R Haddad, SJ Khoury Multiple Sclerosis and Related Disorders 68, 104160, 2022 | | 2022 |
| Long-term exposure to ambient air pollution is associated with increased neuronal injury in people with multiple sclerosis E Vasileiou, C Hu, G Kalaitzidis, H Ehrhardt, H Moussa, G Ahmadi, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 525-525, 2022 | | 2022 |
| Vitreomacular interface abnormalities in multiple sclerosis; a novel signature of disability H Moussa, G Kalaitzidis, H Ehrhardt, OC Murphy, E Vasileiou, G Ahmadi, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 572-573, 2022 | | 2022 |
| Hemi-macular atrophy in multiple sclerosis: a potential representation of trans-synaptic neurodegeneration extending beyond the inner retina G Kalaitzidis, H Moussa, D Ladakis, J Lambe, A Filippatou, E Vasileiou, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 578-579, 2022 | | 2022 |
| Inner and Outer Nuclear Layer Atrophy of the Retina as Novel and Distinguishing Biomarkers for Defining and Tracking Progressive Multiple Sclerosis H Moussa, A DuVal, S Saidha | | 2022 |
| Change in Synaptic Protein Levels in Neuronally-enriched Extracellular Vesicles Mirrors Retinal Layer Atrophy on Optical Coherence Tomography in People with Multiple Sclerosis DC Ladakis, S Kim, JM Blommer, M Vreones, G Kalaitzidis, H Ehrhardt, ... MULTIPLE SCLEROSIS JOURNAL 28 (1_ SUPPL), 26-26, 2022 | | 2022 |
| Should tocilizumab be the first line treatment for neuromyelitis optica together with rituximab? R Sawaya, G Saab, H Moussa Neurologia 36 (8), 642-643, 2021 | | 2021 |
| ¿ Debería ser el tocilizumab el tratamiento de primera línea para la neuromielitis óptica junto con el rituximab? R Sawaya, G Saab, H Moussa Neurología 36 (8), 642-643, 2021 | | 2021 |
| Correlation of pattern reversal and flash visual evoked potentials with optical coherence tomography in patients with optic neuropathy and patients with multiple sclerosis … H Moussa, R Sawaya, N El Ayoubi EUROPEAN JOURNAL OF NEUROLOGY 27, 827-827, 2020 | | 2020 |
